Clinical Trial Update: Drug-induced Xerostomia. Evaluation of Malic Acid 1%, Salivary Mucins and Buffering Capacity [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/Phase 3 clinical trial evaluating malic acid 1% on drug-induced xerostomia with evaluation of salivary mucins and buffering capacity; study completed wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Major Depressive Disorder
• Xerostomia

Drugs mentioned

• Malic acid 1% solution (malic acid)

Snippet

Sponsor: Universidad de Granada | Conditions: Xerostomia, Depression | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2016-04-05